High-titre measles vaccine and female mortality [8]

Lancet

Volumn 362, Issue 9397, 2003, Pages 1765-

  Aaby, Peter ^a,b   Jensen, Henrik ^a   Whittle, Hilton ^c  

^a Danish Epidemiology Science Centre   (Guinea-Bissau)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; HIGH TITRE MEASLES VACCINE; MALARIA VACCINE; MEASLES VACCINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG EFFECT; DRUG SCREENING; FEMALE; HEALTH STATUS; HUMAN; LETTER; MALARIA; MEASLES; MEDICAL EXAMINATION; MORTALITY; MOTHER; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; VACCINATION; VIRUS TITRATION;

EID: 0344552408     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14867-2     Document Type: Letter

References (5)

1. Cutts F.T., Fine P.E.M. Caution - mortality ratios ahead. Lancet. 361:2003;2169-2170.
2. Aaby P., Jensen H., Samb B., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of the West African studies. Lancet. 361:2003;2183-2188.
3. Aaby P., Samb B., Simondon F., et al. Sex specific mortality after high titre measles vaccines in rural Senegal. Bull World Health Organ. 72:1994;761-770.
4. Knudsen K.M., Aaby P., Whittle H., et al. Child mortality following standard, medium and high titre measles vaccination in West Africa. Int J Epidemiol. 25:1996;665-673.
5. Aaby P., Jensen H., Simondon F., Whittle H. High-titre measles vaccination before 9 months of age and increased female mortality: do we have an explanation? Semin Pediatr Infect Dis. 14:2003;220-232.